{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:18:40Z","timestamp":1776878320853,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jiac.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T08:32:33Z","timestamp":1581669153000},"page":"570-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus"],"prefix":"10.1016","volume":"26","author":[{"given":"Mizue","family":"Tsuyuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-3458","authenticated-orcid":false,"given":"Hidetoshi","family":"Igari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.01.011_bib1","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry","year":"2008","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.01.011_bib2","author":"World Health Organization"},{"key":"10.1016\/j.jiac.2020.01.011_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.resinv.2019.07.002","article-title":"Variation of interferon-\u03b3 production between QFT-Plus and QFT-GIT in contact investigation","volume":"57","author":"Tsuyuzaki","year":"2019","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2020.01.011_bib4","first-page":"588","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.01.011_bib5","first-page":"299","article-title":"CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status","volume":"78","author":"Lee","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.01.011_bib6","first-page":"444","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"Infect"},{"key":"10.1016\/j.jiac.2020.01.011_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: a systematic review and meta-analysis","volume":"64","author":"Pourakbari","year":"2019","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.jiac.2020.01.011_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00438-18","article-title":"Comparative evaluation of QuantiFERON-TB gold in-tube and QuantiFERON-TB gold plus in diagnosis of latent tuberculosis infection in immunocompromised patients","volume":"56","author":"Ryu","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.01.011_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB gold plus compared with QuantiFERON-TB gold in-tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2020.01.011_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00427-18","article-title":"QuantiFERON-TB gold plus is a more sensitive screening tool than QuantiFERON-TB gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"Chien","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.01.011_bib11","doi-asserted-by":"crossref","first-page":"e00614","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB gold plus and QuantiFERON-TB gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.01.011_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5588\/ijtld.17.0721","article-title":"Multicenter study of QuantiFERON\u00ae-TB Gold Plus in patients with active tuberculosis","volume":"22","author":"Horne","year":"2018","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.01.011_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2020.01.011_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/eri.12.150","article-title":"IFN-\u03b3 release assay versus tuberculin skin test for monitoring TB infection in healthcare workers","volume":"11","author":"Nienhaus","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2020.01.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","article-title":"QFT-Plus: a plus in variability? - evaluation of new generation IGRA in serial testing of students with a migration background in Germany","volume":"12","author":"Knierer","year":"2017","journal-title":"J\u00a0Occup Med Toxicol"},{"key":"10.1016\/j.jiac.2020.01.011_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.11-0992","article-title":"Challenges of interferon-\u03b3 release assay conversions in serial testing of health-care workers in a TB control program","volume":"142","author":"Fong","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2020.01.011_bib17","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.01.011_bib18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20300258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20300258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:31Z","timestamp":1761159631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20300258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1341321X20300258"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.01.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}